170 related articles for article (PubMed ID: 36124413)
1. HDAC5 inhibits ovarian angiogenesis in dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome.
Wang Y; Wang Y; Chen Y; Gao Q; Hou L; Feng X
Folia Histochem Cytobiol; 2022; 60(3):260-270. PubMed ID: 36124413
[TBL] [Abstract][Full Text] [Related]
2. The effect of cinnamon on polycystic ovary syndrome in a mouse model.
Dou L; Zheng Y; Li L; Gui X; Chen Y; Yu M; Guo Y
Reprod Biol Endocrinol; 2018 Oct; 16(1):99. PubMed ID: 30340496
[TBL] [Abstract][Full Text] [Related]
3. Enhancing angiogenesis and inhibiting apoptosis: evaluating the therapeutic efficacy of bone marrow mesenchymal stem cell-derived exosomes in a DHEA-induced PCOS mouse model.
Teng X; Wang Z; Wang X
J Ovarian Res; 2024 Jun; 17(1):121. PubMed ID: 38840218
[TBL] [Abstract][Full Text] [Related]
4. Dehydroepiandrosterone-induced polycystic ovary syndrome mouse model requires continous treatments to maintain reproductive phenotypes.
Wu H; Zhao B; Yao Q; Kang J
J Ovarian Res; 2023 Oct; 16(1):207. PubMed ID: 37880784
[TBL] [Abstract][Full Text] [Related]
5. Dehydroepiandrosterone induces ovarian and uterine hyperfibrosis in female rats.
Zhang X; Zhang C; Shen S; Xia Yj; Yi L; Gao Q; Wang Y
Hum Reprod; 2013 Nov; 28(11):3074-85. PubMed ID: 23980058
[TBL] [Abstract][Full Text] [Related]
6. Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome.
Bakhshalizadeh S; Amidi F; Alleyassin A; Soleimani M; Shirazi R; Shabani Nashtaei M
Syst Biol Reprod Med; 2017 Jun; 63(3):150-161. PubMed ID: 28345956
[TBL] [Abstract][Full Text] [Related]
7. Protocatechuic acid alleviates polycystic ovary syndrome symptoms in mice by PI3K signaling in granulosa cells to relieve ROS pressure and apoptosis.
Wang F; Yin Y; Nie X; Zou Y; Tong X; Tong Y; Zhou J; Tan Y
Gynecol Endocrinol; 2023 Jun; 39(1):2228917. PubMed ID: 37406659
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D3 affects mitochondrial biogenesis through mitogen-activated protein kinase in polycystic ovary syndrome mouse model.
Safaei Z; Bakhshalizadeh S; Nasr-Esfahani MH; Akbari Sene A; Najafzadeh V; Soleimani M; Shirazi R
J Cell Physiol; 2020 Sep; 235(9):6113-6126. PubMed ID: 32048305
[TBL] [Abstract][Full Text] [Related]
9. Local administration of platelet-derived growth factor B (PDGFB) improves follicular development and ovarian angiogenesis in a rat model of Polycystic Ovary Syndrome.
Di Pietro M; Scotti L; Irusta G; Tesone M; Parborell F; Abramovich D
Mol Cell Endocrinol; 2016 Sep; 433():47-55. PubMed ID: 27256152
[TBL] [Abstract][Full Text] [Related]
10. Effect of Hawthorn Leaf Flavonoids in Dehydroepiandrosterone-Induced Polycystic Ovary Syndrome in Rats.
Shi Y; Kong X; Yin H; Zhang W; Wang W
Pathobiology; 2019; 86(2-3):102-110. PubMed ID: 30404093
[TBL] [Abstract][Full Text] [Related]
11. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
[TBL] [Abstract][Full Text] [Related]
12. Angiopoietins/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome.
Abramovich D; Irusta G; Bas D; Cataldi NI; Parborell F; Tesone M
Endocrinology; 2012 Jul; 153(7):3446-56. PubMed ID: 22577112
[TBL] [Abstract][Full Text] [Related]
13. Hydroxysafflor yellow A exerts beneficial effects by restoring hormone secretion and alleviating oxidative stress in polycystic ovary syndrome mice.
Luo M; Huang JC; Yang ZQ; Wang YS; Guo B; Yue ZP
Exp Physiol; 2020 Feb; 105(2):282-292. PubMed ID: 31803965
[TBL] [Abstract][Full Text] [Related]
14. Exercise-induced irisin improves follicular dysfunction by inhibiting IRE1α-TXNIP/ROS-NLRP3 pathway in PCOS.
Weng Y; Zhang Y; Wang D; Wang R; Xiang Z; Shen S; Wang H; Wu X; Wen Y; Wang Y
J Ovarian Res; 2023 Jul; 16(1):151. PubMed ID: 37525261
[TBL] [Abstract][Full Text] [Related]
15. Kisspeptin regulates the proliferation and apoptosis of ovary granulosa cells in polycystic ovary syndrome by modulating the PI3K/AKT/ERK signalling pathway.
Sun P; Zhang Y; Sun L; Sun N; Wang J; Ma H
BMC Womens Health; 2023 Jan; 23(1):15. PubMed ID: 36627631
[TBL] [Abstract][Full Text] [Related]
16. The ameliorative effects of marjoram in dehydroepiandrosterone induced polycystic ovary syndrome in rats.
Rababa'h AM; Matani BR; Ababneh MA
Life Sci; 2020 Nov; 261():118353. PubMed ID: 32877649
[TBL] [Abstract][Full Text] [Related]
17. Protective Effects of Curcumin against Sodium Arsenite-induced Ovarian Oxidative Injury in a Mouse Model.
Wang XN; Zhang CJ; Diao HL; Zhang Y
Chin Med J (Engl); 2017 May; 130(9):1026-1032. PubMed ID: 28469096
[TBL] [Abstract][Full Text] [Related]
18. The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats.
Wu G; Hu X; Ding J; Yang J
J Ovarian Res; 2020 May; 13(1):57. PubMed ID: 32386521
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of Heqi san on rat model of polycystic ovary syndrome through the PI3K/AKT pathway.
Zhao H; Zhou D; Chen Y; Liu D; Chu S; Zhang S
Daru; 2017 Oct; 25(1):21. PubMed ID: 29020999
[TBL] [Abstract][Full Text] [Related]
20. MiR-185-5p Protects Against Angiogenesis in Polycystic Ovary Syndrome by Targeting VEGFA.
Wei J; Zhao Y
Front Pharmacol; 2020; 11():1030. PubMed ID: 32760272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
